Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125228261 | 12522826 | 1 | I | 201605 | 20160617 | 20160701 | 20160701 | EXP | CA-HQ SPECIALTY-CA-2016INT000424 | INTERCHEM | 78.00 | YR | F | Y | 0.00000 | 20160701 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125228261 | 12522826 | 1 | PS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | 25 MG, UNK | Y | 201749 | 25 | MG | ||||||||
| 125228261 | 12522826 | 2 | SS | ENBREL | ETANERCEPT | 1 | UNK | Y | 0 | ||||||||||
| 125228261 | 12522826 | 3 | SS | SULFASALAZINE. | SULFASALAZINE | 1 | UNK | Y | 0 | ||||||||||
| 125228261 | 12522826 | 4 | SS | LYRICA | PREGABALIN | 1 | UNK | Y | 0 | ||||||||||
| 125228261 | 12522826 | 5 | SS | LEFLUNOMIDE. | LEFLUNOMIDE | 1 | UNK | Y | 0 | ||||||||||
| 125228261 | 12522826 | 6 | SS | ACTEMRA | TOCILIZUMAB | 1 | UNK | Y | 0 | ||||||||||
| 125228261 | 12522826 | 7 | SS | ORENCIA | ABATACEPT | 1 | UNK | Y | 0 | ||||||||||
| 125228261 | 12522826 | 8 | SS | PLAQUENIL /00072602/ | HYDROXYCHLOROQUINE DIPHOSPHATE | 1 | UNK | Y | 0 | ||||||||||
| 125228261 | 12522826 | 9 | SS | MIRTAZAPINE. | MIRTAZAPINE | 1 | 15 MG, UNK | 0 | 15 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125228261 | 12522826 | 1 | Rheumatoid arthritis |
| 125228261 | 12522826 | 2 | Rheumatoid arthritis |
| 125228261 | 12522826 | 3 | Rheumatoid arthritis |
| 125228261 | 12522826 | 4 | Rheumatoid arthritis |
| 125228261 | 12522826 | 5 | Product used for unknown indication |
| 125228261 | 12522826 | 6 | Product used for unknown indication |
| 125228261 | 12522826 | 7 | Product used for unknown indication |
| 125228261 | 12522826 | 8 | Product used for unknown indication |
| 125228261 | 12522826 | 9 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125228261 | 12522826 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125228261 | 12522826 | Drug intolerance | |
| 125228261 | 12522826 | Pneumonitis | |
| 125228261 | 12522826 | Pyelonephritis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |